The next ten years will be marked by significant technological developments in health care and biotechnology, which will drastically change the assumptions and perceptions of life and death. This report is designed to assist diagnostics industry executives in exploring the impact of possible technological developments and commercialization of a number of new products, and formulating policy alternatives that will provide the best choice among possible courses of action.
This invaluable strategic planning resource is designed to help corporate, marketing and R&D executives develop effective business plans that best accommodate uncertainties ahead. The report:- Evaluates emerging technologies that may present unexpected threats or offer opportunities
- Identifies key strategic decisions that will have to be made in the future
- Enhances corporate ability to develop realistic contingency plans.
The report explores the impact of the most significant technological developments of the next ten years and their impact on the U.S. in vitro diagnostics market, including major testing locations (hospitals, commercial labs, physician offices, blood centers, POC sites), and laboratory disciplines (blood banking, clinical chemistry, immunodiagnostics, coagulation, hematology, flow cytometry, histology, cytology, microbiology, serology, urinalysis).
Contains 85 pages and 8 tables